SOURCE: Mediware Information Systems

September 10, 2008 17:01 ET

Mediware Announces Prestigious Speakers for Annual Customer Conference

Dr. James AuBuchon and Others to Provide Industry Insights During Blood Management Conference on Oct. 8, 2008

LENEXA, KS--(Marketwire - September 10, 2008) - Mediware Information Systems, Inc. (NASDAQ: MEDW) announced that it will host its annual customer conference on October 8, 2008, following the American Association of Blood Banks (AABB) conference in Montreal. The event will feature prestigious industry speakers as well as best practice sessions that deliver continuing education credit to participants. More than 150 attendees are expected and all Mediware hospital blood management and blood center customers are eligible to attend. Registration information is available on Mediware's web site,

Headlining the event is Dr. James AuBuchon, who on September 1 assumed the position of President and Chief Executive Officer of Seattle's Puget Sound Blood Center, one of the world's largest centralized transfusion services. Dr. AuBuchon, who previously led transfusion medicine at the prestigious Dartmouth Hitchcock Medical Center, has been a long time advocate for the effective management and use of blood. He is also one of the thought leaders behind the U.S. Biovigilance Network, a program that is developing through the cooperation of industry trade groups, corporations, healthcare institutions and the federal government.

Dr. AuBuchon will bring his unique background to the Mediware customer conference audience, which will include both blood center and hospital blood bank professionals. His presentation will consider the future of a demand-driven blood supply and the possibility of recruiting, tracking and delivering the exact blood products needed for specific patients and procedures. He'll trace the process of a patient from doctor's office visit through surgery and contemplate the systems, departmental and organizational coordination required.

Dr. AuBuchon's topic is of particular interest to Mediware and its customers because of its applicability to the company's stated growth programs. These include the integrated blood center through Mediware's Blood Center Technologies group (BCT) as well as Mediware's latest hospital blood products, including HCLL™ Transfusion, BloodSafe™ and BiologiCare™.

Also on the agenda for the customer conference is Dr. Cassandra Josephson of Emory University Hospital. Dr. Josephson specializes in pediatric transfusion safety and will speak specifically about her experience launching centralized tissue management in her hospital and how this has improved the safety and efficiency surrounding these products. Centralized tissue management is an emerging trend for hospitals and the driving force behind Mediware's newest product, BiologiCare™.

Other featured speakers include:

-- Dr. Jeannie Callum, Director of Transfusion Medicine and Tissue Bank at Toronto's Sunnybrook Health Sciences Centre, and Lyn Sharman, president of Neoteric Technology Ltd., will co-present product results relating to remote blood storage and point-of-care transfusion administration.

-- Rose Campbell, president of RBC Technologies, will present best practices for validating blood bank systems requiring FDA clearance for use.

The Mediware customer conference will be held at the Fairmont Queen Elizabeth hotel in Montreal and is open to all current customers of Mediware's hospital and blood center technology products. Prior to the October 8 event, Mediware will be demonstrating all of its latest products in AABB booth #1811.

For additional information on Mediware products or the annual blood management customer conference, visit

About Mediware

Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world.

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2008, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

Contact Information

  • Contact:
    John Van Blaricum